Clinical Trials · NCT05781217
Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624
- Phase
- Phase 3
- Recruitment status
- Recruiting
- Sponsor
- Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic
- Enrollment
- 534
- Start date
- Mar 2023
- Locations
- 17 sites, Spain
- Primary endpoint
- To compare 5-year MFS rates in prostate cancer patients treated with long- versus short-term ADT in combination with salvage radiotherapy